Physician profile
Aaron Hoffman
NPI 1902010788
$12,887.59
in general payments reported to CMS, 2019-2025
21 companies · $1,069 in 2025
The $1,069 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,214 · 2020: $375 · 2021: $1,127 · 2022: $190 · 2023: $239 · 2024: $675 · 2025: $1,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,982.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $10,071.28 | 2019-2025 | |
| Atricure, INC. | $854.90 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Zimmer Biomet Holdings, INC. | $519.08 | 2023-2025 | Sternalock Blu System, Advantagerib, Venapax |
| Intuitive Surgical, INC. | $332.40 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $214.36 | 2025 | |
| Abiomed | $190.33 | 2024-2025 | Impella |
| Stryker Corporation | $183.77 | 2023 | Aequalis Ascend Flex, 1788 |
| Medtronic, INC. | $126.59 | 2022-2023 | Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $111.11 | 2019 | |
| Medtronic Vascular, INC. | $50.85 | 2019-2020 | |
| Chiesi USA, INC. | $40.77 | 2020 | |
| Pfizer INC. | $31.38 | 2019 | |
| Amgen INC. | $30.92 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $23.65 | 2019 | |
| Livanova USA, INC. | $19.98 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $19.13 | 2020 | |
| Olympus America INC. | $16.28 | 2019 | |
| Haemonetics Corporation | $13.81 | 2025 | Teg6s Hemostasis System |
| Elutia, INC. | $13.37 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.26 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.